▁ 4.109375
8 3.849609375
% 6.42578125
▁of 1.0673828125
▁the 2.35546875
▁residents 6.44921875
▁of 0.7294921875
▁progress 12.59375
ive 0.04425048828125
▁countries 6.578125
▁still 5.21875
▁consider 4.0703125
▁chron 11.2265625
ic 0.08221435546875
▁pain 1.9501953125
▁to 1.2685546875
▁be 0.0180816650390625
▁an 2.517578125
▁extreme 7.578125
▁issue 4.4296875
. 0.9072265625
▁The 2.525390625
▁introduction 7.03515625
▁of 0.029205322265625
▁the 2.119140625
▁study 7.421875
▁describes 7.71875
▁the 0.724609375
▁apparent 8.75
▁link 5.08984375
▁between 0.1365966796875
▁pain 2.4296875
▁and 0.290771484375
▁dem 6.95703125
oral 3.248046875
ization 0.1341552734375
. 0.92041015625
▁Chron 4.1484375
ic 0.003162384033203125
▁pain 0.124267578125
▁is 1.078125
▁always 6.09765625
▁accompanied 2.79296875
▁by 0.021484375
▁negative 4.09765625
▁emot 0.66357421875
ional 1.61328125
▁experiences 2.380859375
▁and 2.162109375
▁blocks 10.2734375
▁a 3.1640625
▁person 0.367431640625
’ 0.7900390625
s 0.0004019737243652344
▁ability 1.306640625
▁to 0.016632080078125
▁receive 6.64453125
▁joy 3.345703125
▁and 1.5361328125
▁satisfaction 2.962890625
▁from 0.787109375
▁life 0.53662109375
. 0.1634521484375
▁The 2.216796875
▁research 2.724609375
▁investig 7.46484375
ates 0.7939453125
▁the 0.50439453125
▁development 5.65625
▁of 0.1270751953125
▁de 4.4453125
pression 0.409912109375
▁and 1.431640625
▁anx 1.2822265625
iety 0.0005326271057128906
▁among 2.26171875
▁patients 1.46484375
▁receiving 5.8203125
▁ph 5.48828125
arma 3.24609375
ce 0.0095367431640625
ut 0.00038051605224609375
ical 0.0026035308837890625
▁op 4.5546875
io 0.0819091796875
ids 0.348876953125
▁and 2.580078125
▁medical 3.609375
▁mar 1.64453125
iju 0.0008969306945800781
ana 4.303455352783203e-05
▁( 3.478515625
MM 1.61328125
) 3.046875
▁as 2.859375
▁severe 9.9296875
▁pain 0.712890625
kill 2.4375
ers 0.0004794597625732422
. 0.19189453125
▁It 3.625
▁comp 4.82421875
ares 0.005542755126953125
▁the 0.5908203125
▁effic 4.10546875
acy 0.0010118484497070312
▁of 0.2064208984375
▁pres 6.140625
cri 2.01953125
ptions 1.3798828125
▁and 1.9306640625
▁exam 4.65234375
ines 0.009002685546875
▁the 0.446044921875
▁possibility 3.90625
▁of 0.05328369140625
▁post 8.09375
- 0.59619140625
tre 1.978515625
at 0.0009489059448242188
ment 0.0020313262939453125
▁de 1.8037109375
pression 0.07452392578125
. 1.1416015625
▁There 6.00390625
▁is 1.044921875
▁currently 5.27734375
▁a 1.23046875
▁severe 4.91796875
▁lack 2.0703125
▁of 0.0108489990234375
▁information 2.025390625
▁about 1.279296875
▁the 0.548828125
▁effects 3.0546875
▁of 0.0596923828125
▁op 3.37109375
i 3.3828125
ates 0.0142364501953125
. 3.083984375
▁They 5.23046875
▁manage 8.3046875
▁pain 2.876953125
▁successfully 6.0390625
, 0.818359375
▁but 0.1629638671875
▁the 2.46875
▁past 9.109375
▁few 1.9091796875
▁dec 1.3037109375
ades 1.537799835205078e-05
▁indicated 8.359375
▁the 1.880859375
▁growing 3.69140625
▁concern 3.734375
▁regarding 2.939453125
▁op 2.4140625
iate 1.234375
▁ab 1.51171875
use 0.01104736328125
▁in 3.8515625
▁forms 9.609375
▁of 0.3203125
▁over 3.150390625
d 0.0985107421875
ose 0.282470703125
▁and 0.6787109375
▁add 0.65283203125
iction 0.015838623046875
. 0.099365234375
▁A 4.3046875
▁more 4.875
▁manage 7.91796875
able 0.0005559921264648438
▁and 2.03515625
▁sa 2.046875
fer 9.47713851928711e-05
▁alternative 1.2626953125
▁might 5.390625
▁be 0.125244140625
▁medical 1.7431640625
▁mar 0.215087890625
iju 0.0007424354553222656
ana 0.00012433528900146484
. 0.7373046875
▁However 4.046875
, 0.004352569580078125
▁the 1.7216796875
▁legal 4.015625
▁status 1.0732421875
▁and 3.033203125
▁novel 9.671875
ty 0.1341552734375
▁of 0.134033203125
▁this 2.40625
▁drug 1.546875
▁do 4.59375
▁not 0.01312255859375
▁allow 0.68115234375
▁finding 7.10546875
▁a 2.3359375
▁large 2.6171875
▁number 0.853515625
▁of 0.00247955322265625
▁studies 1.1669921875
▁on 1.64453125
▁its 0.78857421875
▁effect 2.298828125
iveness 0.2369384765625
. 0.63330078125
▁Specifically 9.078125
, 0.047882080078125
▁it 2.75390625
▁concerns 5.25390625
▁the 0.8779296875
▁emot 6.5390625
ional 0.017364501953125
▁condition 4.5234375
▁of 0.21044921875
▁patients 0.6337890625
▁experien 5.4140625
cing 6.80685043334961e-05
▁chron 0.767578125
ic 0.00044083595275878906
▁pain 0.0518798828125
. 0.414794921875
▁This 2.912109375
▁research 1.9580078125
▁paper 4.2578125
▁a 1.8408203125
ims 0.0003807544708251953
▁to 0.08575439453125
▁analyze 3.142578125
▁levels 10.125
▁of 0.0235595703125
▁de 0.50146484375
pression 0.0251922607421875
▁and 0.19775390625
▁anx 0.02703857421875
iety 0.00039005279541015625
▁among 0.87109375
▁people 2.6953125
▁receiving 2.279296875
▁ther 6.578125
apy 0.10064697265625
▁by 4.640625
▁comparing 7.99609375
▁the 1.4775390625
▁effects 2.11328125
▁of 0.02630615234375
▁ph 2.998046875
arma 0.029083251953125
ce 0.0035076141357421875
ut 0.00014412403106689453
ical 0.0031719207763671875
▁op 0.11444091796875
io 0.54248046875
ids 0.034515380859375
▁and 0.2347412109375
▁MM 0.481201171875
. 0.298095703125
▁The 1.40234375
▁study 1.875
▁was 3.658203125
▁conducted 0.65283203125
▁in 1.193359375
▁the 1.4111328125
▁form 2.931640625
▁of 0.0022487640380859375
▁collection 11.921875
▁and 0.7109375
▁analysis 0.41015625
▁of 0.01119232177734375
▁statistical 3.61328125
▁data 0.127197265625
. 1.095703125
▁Part 5.52734375
icip 0.1865234375
ants 0.05877685546875
▁were 0.78662109375
▁rec 3.931640625
ru 0.0010776519775390625
ited 0.00017774105072021484
▁for 4.2109375
▁six 6.88671875
▁months 0.4111328125
▁at 3.90234375
▁two 2.603515625
▁major 4.11328125
▁pain 2.517578125
▁relief 4.02734375
▁cent 0.82958984375
ers 0.03826904296875
▁in 0.59521484375
▁Israel 5.3671875
. 0.3408203125
▁The 1.162109375
▁research 2.42578125
ers 1.7490234375
▁used 2.17578125
▁The 6.8125
▁De 3.072265625
pression 0.0224456787109375
▁Module 6.93359375
▁of 0.8037109375
▁the 0.233154296875
▁Pat 3.306640625
ient 0.00994873046875
▁Health 0.03155517578125
▁Question 0.0192108154296875
naire 0.0229644775390625
▁and 2.583984375
▁the 0.88525390625
▁General 1.169921875
ized 0.59619140625
▁An 0.0049896240234375
x 9.322166442871094e-05
iety 0.00043463706970214844
▁Dis 0.1861572265625
order 0.0203094482421875
▁Sc 1.400390625
ale 0.0031070709228515625
▁to 0.91943359375
▁interview 7.74609375
▁participants 2.55078125
, 4.3203125
▁evaluate 4.5078125
▁their 0.61083984375
▁answers 3.994140625
, 0.3134765625
▁and 0.038543701171875
▁conduct 4.859375
▁the 1.9140625
▁study 2.142578125
. 0.07696533203125
▁The 0.72998046875
▁study 2.080078125
▁used 4.6484375
▁multiple 5.6171875
▁regression 1.81640625
▁analysis 0.703125
▁to 0.467041015625
▁compare 2.4453125
▁the 0.61376953125
▁prob 8.078125
abilities 0.0049285888671875
▁of 0.09521484375
▁de 1.1533203125
pression 0.050048828125
▁and 0.2144775390625
▁anx 0.0276947021484375
iety 0.0002949237823486328
▁among 1.1376953125
▁diverse 9.171875
▁groups 0.583984375
▁and 3.40234375
▁chose 6.8828125
▁medical 4.55859375
▁mar 0.069091796875
iju 0.0006227493286132812
ana 3.993511199951172e-05
▁as 0.281494140625
▁the 0.89208984375
▁control 3.890625
▁group 0.68603515625
. 0.346923828125
▁Direct 10.7578125
▁responses 7.6484375
▁from 1.51953125
▁a 4.6796875
▁large 3.134765625
▁number 0.459228515625
▁of 0.002471923828125
▁participants 1.3154296875
▁make 4.70703125
▁this 1.4462890625
▁type 6.84765625
▁of 0.002399444580078125
▁study 1.1005859375
▁the 3.34765625
▁most 0.325927734375
▁reve 7.5703125
aling 0.00036215782165527344
▁and 1.212890625
▁inclus 7.30859375
ive 0.0005402565002441406
. 0.5185546875
▁All 5.7421875
▁tools 8.1796875
▁in 5.04296875
▁the 0.65576171875
▁form 5.37109375
▁of 0.034698486328125
▁question 0.7978515625
na 0.01128387451171875
ires 0.00020039081573486328
▁and 1.2939453125
▁scales 2.587890625
▁have 3.181640625
▁already 4.49609375
▁been 0.41650390625
▁used 2.087890625
▁and 2.029296875
▁proved 2.375
▁their 1.1845703125
▁effic 2.634765625
acy 0.0027141571044921875
▁for 3.7265625
▁collect 4.1171875
ing 0.00472259521484375
▁analyt 7.15234375
ical 0.0911865234375
▁data 0.1650390625
. 0.329833984375
▁It 3.861328125
▁helps 4.15625
▁to 0.71240234375
▁system 6.9375
at 0.48681640625
ize 0.0017938613891601562
▁and 1.431640625
▁class 4.8203125
ify 0.001399993896484375
▁distinct 8.40625
▁kinds 6.21484375
▁of 0.0138702392578125
▁information 2.150390625
▁for 3.908203125
▁subsequent 5.03515625
▁un 8.6640625
comp 4.34375
licated 0.01715087890625
▁services 12.6015625
. 0.50048828125
▁Thus 4.99609375
, 0.0085601806640625
▁research 4.41796875
ers 0.3486328125
▁can 1.6435546875
▁compare 2.583984375
▁the 0.99365234375
▁effects 2.75390625
▁of 0.076171875
▁medic 3.8671875
ations 0.67236328125
▁on 1.5185546875
▁patients 1.994140625
▁of 4.234375
▁diverse 2.826171875
▁age 1.802734375
▁groups 1.9541015625
, 0.791015625
▁background 3.88671875
s 0.12237548828125
, 0.013458251953125
▁physical 5.59765625
▁conditions 1.2958984375
, 0.033447265625
▁emot 6.3046875
ional 0.0231475830078125
▁states 1.337890625
, 0.040740966796875
▁and 0.36328125
▁so 2.755859375
▁on 0.2071533203125
. 0.0655517578125
▁The 1.0205078125
▁analysis 3.51171875
▁of 1.0205078125
▁any 8.453125
▁human 6.73828125
▁reaction 3.85546875
▁has 4.765625
▁a 1.736328125
▁high 2.92578125
▁potential 3.099609375
▁of 2.412109375
▁subject 4.26171875
iveness 3.716796875
▁and 1.2763671875
▁bias 1.888671875
, 1.83984375
▁especially 2.494140625
▁regarding 3.759765625
▁people 4.80078125
▁in 3.677734375
▁severe 2.57421875
▁pain 0.55712890625
▁and 2.41015625
▁un 5.78125
stable 0.9453125
▁emot 0.67236328125
ional 0.08038330078125
▁condition 2.40234375
. 0.04986572265625
▁Perhaps 8.859375
▁some 5.2734375
▁patients 2.10546875
▁tend 4.6640625
▁to 0.0086212158203125
▁ex 1.8154296875
agger 0.0101776123046875
ate 0.0014448165893554688
▁their 0.90234375
▁de 3.310546875
press 1.9140625
ive 0.0638427734375
▁state 2.34375
▁or 1.791015625
▁vice 5.66015625
▁vers 0.022552490234375
a 1.919269561767578e-05
, 1.138671875
▁de 7.265625
- 2.587890625
emph 0.43896484375
as 0.0021572113037109375
ize 0.058197021484375
▁serious 6.76171875
▁difficulties 5.47265625
. 0.74658203125
▁Because 6.45703125
▁the 2.822265625
▁survey 4.75390625
▁responses 6.453125
▁were 1.4072265625
▁thoroughly 8.3828125
▁anonymous 3.005859375
, 0.25048828125
▁the 1.22265625
▁research 0.9521484375
ers 0.18212890625
▁were 2.529296875
▁unable 3.107421875
▁to 0.0014820098876953125
▁carefully 8.3828125
▁analyze 2.583984375
▁each 2.314453125
▁patient 2.3828125
’ 0.54248046875
s 0.001049041748046875
▁reaction 3.92578125
▁and 1.4375
▁compare 3.85546875
▁it 0.82666015625
▁to 0.57421875
▁the 1.0361328125
▁actual 4.3359375
▁states 7.7578125
▁of 0.62158203125
▁condition 7.17578125
. 0.361328125
▁More 6.0234375
▁accurate 3.37109375
▁answers 4.28125
▁could 1.9521484375
▁be 0.79931640625
▁obtained 0.943359375
▁by 1.376953125
▁professional 6.05859375
▁psych 1.1240234375
olog 0.36962890625
ists 0.001117706298828125
▁via 7.171875
▁personal 2.6015625
▁communication 4.27734375
▁and 2.025390625
▁behavior 6.16796875
al 0.242919921875
▁analysis 2.037109375
. 0.279052734375
▁However 1.69140625
, 0.0004482269287109375
▁this 1.5986328125
▁method 2.16796875
▁of 2.341796875
▁research 1.998046875
▁is 1.119140625
▁way 6.08203125
▁more 0.8564453125
▁resource 4.48046875
- 0.248291015625
int 1.275390625
ensive 0.019317626953125
▁and 0.4365234375
▁energy 10.8515625
- 0.07196044921875
consum 0.358154296875
ing 0.0015087127685546875
. 0.6806640625
▁Part 6.0390625
icip 0.3212890625
ants 0.177490234375
▁were 1.73046875
▁rec 2.267578125
ru 0.00046324729919433594
ited 1.049041748046875e-05
▁for 1.7177734375
▁six 0.300537109375
▁months 0.005382537841796875
▁at 0.438720703125
▁two 0.06976318359375
▁major 0.1094970703125
▁pain 0.035125732421875
▁relief 0.0281219482421875
▁cent 0.01419830322265625
ers 0.0008702278137207031
▁in 0.044830322265625
▁Israel 0.012420654296875
. 0.1676025390625
▁All 3.73828125
▁patients 2.0390625
▁experienced 4.43359375
▁chron 0.751953125
ic 0.00017333030700683594
▁pain 0.149658203125
▁for 2.484375
▁at 0.869140625
▁least 0.00156402587890625
▁ 2.068359375
3 1.4921875
▁months 0.255859375
. 1.1826171875
▁The 1.2841796875
▁study 1.7783203125
▁included 1.6865234375
▁ 0.59228515625
8 3.0
9 2.5390625
0 3.029296875
▁participants 1.5234375
, 1.5595703125
▁of 2.6640625
▁which 0.45166015625
▁ 0.094970703125
4 1.4296875
7 2.578125
4 2.65234375
▁( 3.146484375
5 0.089111328125
9 4.9765625
%) 0.740234375
▁were 0.771484375
▁treated 3.375
▁sole 6.69921875
ly 6.318092346191406e-05
▁with 0.26416015625
▁op 1.4208984375
io 0.34326171875
ids 0.1312255859375
, 0.46337890625
▁ 0.55126953125
3 1.255859375
2 2.23046875
9 2.521484375
▁( 0.042236328125
4 2.41796875
1 1.2099609375
%) 0.05517578125
▁were 1.4775390625
▁treated 0.501953125
▁with 0.39990234375
▁MM 0.568359375
, 0.357666015625
▁and 0.0904541015625
▁ 0.224365234375
7 1.9384765625
7 2.419921875
▁( 0.09234619140625
8 2.013671875
. 0.9404296875
6 2.365234375
%) 0.0777587890625
▁acquired 10.5859375
▁both 0.5966796875
▁( 4.828125
Fe 9.40625
ing 1.3056640625
old 0.400390625
▁et 1.0302734375
▁al 0.0263214111328125
., 0.191650390625
▁ 0.01262664794921875
2 0.010589599609375
0 0.0003948211669921875
1 0.331298828125
7 1.736328125
). 0.054290771484375
▁The 0.91943359375
▁remaining 7.80078125
▁ten 6.5546875
▁participants 1.3125
▁who 5.05859375
▁did 2.40625
▁not 0.006320953369140625
▁receive 2.18359375
▁ph 3.8671875
arma 0.10009765625
ce 0.0007948875427246094
ut 3.2186508178710938e-06
ical 0.00247955322265625
▁op 1.38671875
io 0.044525146484375
ids 0.02142333984375
▁and 2.34375
▁medical 1.69921875
▁mar 0.03851318359375
iju 0.00024080276489257812
ana 4.0531158447265625e-05
▁were 0.5009765625
▁with 6.703125
dra 0.054840087890625
wn 6.92605972290039e-05
▁from 0.2176513671875
▁the 0.1815185546875
▁analysis 2.369140625
▁in 5.05859375
▁the 1.2119140625
▁research 4.29296875
. 1.1396484375
▁Therefore 4.984375
, 0.01678466796875
▁it 3.783203125
▁is 1.2099609375
▁not 2.658203125
▁possible 0.68310546875
▁to 0.007015228271484375
▁compreh 6.06640625
ens 0.1795654296875
ively 0.0194854736328125
▁compare 1.328125
▁patients 4.9765625
▁taking 3.732421875
▁medic 4.125
ations 0.5673828125
▁with 1.4013671875
▁those 1.091796875
▁who 0.79052734375
▁do 1.3798828125
▁not 0.0048675537109375
. 0.572265625
▁The 1.322265625
▁study 1.6982421875
▁conducted 4.45703125
▁a 1.732421875
▁correlation 6.0234375
▁type 9.3984375
▁of 0.232177734375
▁research 1.0625
▁with 3.423828125
▁variable 8.3828125
▁measures 4.98828125
. 0.89208984375
▁It 1.6484375
▁evaluated 5.48828125
▁the 0.57568359375
▁inter 6.12890625
dep 2.330078125
end 0.00021755695343017578
ence 0.0067901611328125
▁of 0.544921875
▁various 3.23828125
▁factors 0.92578125
▁that 2.955078125
▁affected 4.0625
▁the 0.44677734375
▁physical 6.3203125
▁and 0.251708984375
▁emot 0.44921875
ional 9.822845458984375e-05
▁condition 1.361328125
▁of 0.034820556640625
▁patients 0.7158203125
▁experien 2.92578125
cing 9.5367431640625e-07
▁chron 0.2113037109375
ic 0.00017380714416503906
▁pain 0.00957489013671875
. 0.131103515625
▁For 4.23828125
▁example 1.06640625
, 0.001743316650390625
▁the 1.06640625
▁survey 5.6171875
▁showed 4.0078125
▁that 0.46826171875
▁the 1.9130859375
▁ratio 6.73046875
▁of 0.08355712890625
▁female 3.599609375
▁patients 0.8837890625
▁was 1.345703125
▁remark 8.0625
ably 0.00016248226165771484
▁higher 0.177734375
▁in 2.28515625
▁the 0.4462890625
▁op 3.765625
i 3.587890625
ates 0.01348876953125
▁group 0.198974609375
▁compared 2.4296875
▁to 0.040863037109375
▁the 0.595703125
▁MM 0.1610107421875
▁group 0.3095703125
. 0.43701171875
▁In 3.505859375
▁turn 4.12109375
, 0.0010652542114257812
▁people 4.87109375
▁on 4.6796875
▁op 3.142578125
i 0.61962890625
ates 0.003528594970703125
▁were 0.9609375
▁more 1.3408203125
▁likely 0.266845703125
▁to 0.0254974365234375
▁report 2.87890625
▁major 6.04296875
▁de 0.47705078125
press 0.7109375
ive 0.0022449493408203125
▁dis 0.9033203125
orders 1.5390625
. 1.55078125
▁The 1.6025390625
▁question 5.58203125
na 1.1337890625
ires 0.00027251243591308594
▁used 2.474609375
▁different 6.84765625
▁variable 8.0234375
▁measures 0.297607421875
▁to 1.884765625
▁collect 2.50390625
▁information 1.5478515625
. 1.4560546875
▁For 1.5615234375
▁example 0.280517578125
, 0.001674652099609375
▁it 4.078125
▁included 1.892578125
▁compreh 8.359375
ensive 0.05322265625
▁so 5.41796875
cio 0.0009899139404296875
- 0.27001953125
dem 0.13525390625
ographic 0.06732177734375
▁data 0.88818359375
: 4.9609375
▁gender 2.033203125
, 0.04046630859375
▁age 0.280029296875
, 0.035400390625
▁country 4.18359375
, 2.474609375
▁type 4.46875
▁of 0.05523681640625
▁residence 3.990234375
▁( 2.63671875
urban 0.6728515625
/ 1.3427734375
r 0.15625
ural 0.0008654594421386719
), 0.1817626953125
▁years 6.2890625
▁of 0.176025390625
▁education 0.76123046875
, 0.08837890625
▁and 1.458984375
▁employ 2.5390625
ment 0.0016622543334960938
▁status 0.6611328125
. 0.177001953125
▁Pat 4.4375
ients 0.0845947265625
▁were 1.3134765625
▁also 0.93798828125
▁asked 0.50439453125
▁about 1.0185546875
▁their 0.67236328125
▁medical 2.474609375
▁history 0.5615234375
▁over 8.7109375
▁the 0.058929443359375
▁years 4.6484375
▁and 1.6826171875
▁the 1.484375
▁current 2.982421875
▁presence 5.09375
▁of 0.07550048828125
▁any 2.255859375
▁severe 3.529296875
▁dise 1.78515625
ases 6.532669067382812e-05
▁such 4.375
▁as 0.0011167526245117188
▁heart 2.51171875
▁failure 1.7255859375
, 0.285400390625
▁di 1.591796875
ab 0.0006136894226074219
etes 0.002330780029296875
, 0.060577392578125
▁ar 4.078125
th 0.14404296875
rit 0.0253448486328125
is 0.0037670135498046875
, 0.025360107421875
▁and 1.1923828125
▁so 0.7734375
▁on 0.051727294921875
. 0.052825927734375
▁The 1.3515625
▁third 7.0234375
▁measure 3.638671875
▁of 2.125
▁the 0.5244140625
▁question 2.017578125
naire 0.278564453125
▁was 1.1796875
▁indicated 10.7421875
▁by 1.189453125
▁information 6.6953125
▁on 2.015625
▁any 5.70703125
▁twelve 14.28125
- 0.2183837890625
month 0.168212890625
▁and 5.0
▁lifetime 0.59765625
▁drug 3.240234375
▁and 1.5712890625
▁alco 0.1292724609375
hol 6.73532485961914e-05
▁consumption 4.69140625
. 0.40576171875
▁In 3.251953125
▁addition 1.056640625
, 0.285400390625
▁the 0.984375
▁record 10.203125
▁included 1.33984375
▁a 2.71484375
▁pain 4.6328125
▁measurement 4.98046875
▁scale 0.76220703125
▁from 4.3671875
▁ 0.54248046875
0 0.29248046875
▁to 0.2325439453125
▁ 0.006595611572265625
1 0.07415771484375
0 0.035247802734375
▁to 3.09765625
▁evaluate 1.6298828125
▁dis 6.00390625
com 0.10565185546875
fort 0.0017614364624023438
▁feelings 8.2109375
▁during 4.125
▁the 0.281005859375
▁last 0.9794921875
▁month 1.7197265625
. 0.2415771484375
▁Among 6.16796875
▁all 2.439453125
▁participants 2.376953125
▁in 4.0546875
▁the 0.1966552734375
▁study 0.52490234375
, 0.0340576171875
▁ 0.72119140625
4 1.8603515625
2 2.37109375
. 1.1943359375
2 2.23046875
% 0.068359375
▁suffered 3.751953125
▁from 0.0693359375
▁de 2.09765625
pression 0.28662109375
, 0.869140625
▁and 1.2197265625
▁ 0.10479736328125
3 1.4716796875
7 2.365234375
% 2.611328125
▁experienced 1.998046875
▁excess 6.85546875
ive 0.0249176025390625
▁anx 0.253173828125
iety 0.001728057861328125
. 0.406982421875
▁The 1.3876953125
▁pl 11.0078125
ur 0.7412109375
ality 0.0010738372802734375
▁of 0.09918212890625
▁de 2.43359375
press 1.2216796875
ive 0.0244140625
▁dis 2.279296875
orders 0.07220458984375
▁among 3.142578125
▁patients 0.990234375
▁in 2.787109375
▁the 0.26318359375
▁op 0.474365234375
i 0.397216796875
ates 0.0015430450439453125
, 9.296875
▁medical 4.12890625
▁mar 0.02777099609375
iju 0.000591278076171875
ana 2.5272369384765625e-05
, 0.2117919921875
▁and 0.0645751953125
▁mixed 1.6552734375
▁OP 11.4296875
MM 4.17578125
▁groups 0.49951171875
▁number 9.3125
ed 0.02288818359375
▁ 0.161376953125
5 1.6953125
7 2.65234375
. 0.478759765625
1 2.525390625
%, 0.1982421875
▁ 0.0032634735107421875
2 1.8818359375
2 2.671875
. 0.1041259765625
3 2.2734375
%, 0.05133056640625
▁and 0.052337646484375
▁ 0.001739501953125
5 2.09375
1 2.0703125
. 0.1558837890625
4 1.908203125
%, 0.153076171875
▁respectively 0.020965576171875
. 0.259765625
▁The 1.15625
▁pl 3.892578125
ur 0.0084075927734375
ality 5.2809715270996094e-05
▁of 0.0203704833984375
▁anx 0.46826171875
iety 0.0163116455078125
▁contained 10.9921875
▁ 0.2479248046875
4 1.1171875
8 2.37109375
. 0.172607421875
4 2.197265625
% 2.0234375
▁among 2.5234375
▁OP 5.28125
▁patients 6.078125
, 0.26904296875
▁ 0.07574462890625
2 0.962890625
1 2.52734375
. 0.1094970703125
5 2.130859375
% 0.024688720703125
▁among 0.468505859375
▁MM 0.10308837890625
▁patients 0.35302734375
, 0.017730712890625
▁and 0.0142059326171875
▁ 0.0242767333984375
3 1.388671875
8 1.912109375
. 0.129638671875
7 2.205078125
% 0.0118865966796875
▁among 0.1954345703125
▁OP 1.951171875
MM 0.126220703125
▁participants 3.275390625
. 0.2371826171875
▁Pat 4.46875
ients 0.017852783203125
▁who 1.9423828125
▁took 2.181640625
▁strong 9.59375
▁op 0.6494140625
i 0.79736328125
ates 0.002811431884765625
▁were 1.294921875
▁t 10.296875
ended 1.1015625
▁to 0.007480621337890625
▁place 9.7109375
▁their 1.9990234375
▁pain 0.98974609375
▁on 1.8720703125
▁a 0.5849609375
▁scale 1.822265625
▁of 0.411865234375
▁ 0.11376953125
9 2.501953125
▁to 2.1953125
▁ 0.01119232177734375
1 0.0049591064453125
0 0.005218505859375
▁( 2.76953125
Fe 1.6240234375
ing 0.002193450927734375
old 0.0003733634948730469
▁et 0.0159149169921875
▁al 0.00165557861328125
., 0.01018524169921875
▁ 0.0014209747314453125
2 0.00017499923706054688
0 2.849102020263672e-05
1 0.0016946792602539062
7 0.006649017333984375
). 0.010650634765625
▁They 3.58203125
▁were 1.7294921875
▁also 1.1259765625
▁an 9.625
gu 4.71875
ished 0.07672119140625
▁em 6.06640625
otion 0.0008120536804199219
ally 0.0007200241088867188
▁and 1.162109375
▁react 7.44140625
ed 0.022552490234375
▁rad 9.078125
ically 0.0011043548583984375
▁neg 4.703125
atively 0.0012378692626953125
▁to 0.175537109375
▁almost 5.4296875
▁all 1.6552734375
▁survey 3.791015625
▁questions 0.2320556640625
. 0.2998046875
▁Pat 2.75390625
ients 0.004863739013671875
▁who 1.1416015625
▁only 5.71875
▁took 1.24609375
▁MM 0.3916015625
▁or 3.404296875
▁mixed 2.59765625
▁medic 1.5615234375
ations 0.234375
▁had 2.369140625
▁a 1.2451171875
▁more 1.916015625
▁stable 2.080078125
▁emot 0.8720703125
ional 0.00042557716369628906
▁state 0.56787109375
. 1.1806640625
▁One 6.41796875
▁of 0.63916015625
▁the 0.036773681640625
▁major 3.177734375
▁limitations 3.380859375
▁is 3.36328125
▁the 0.53515625
▁ins 4.65625
u 0.07025146484375
fficient 0.0611572265625
ly 3.62890625
▁high 2.94140625
▁response 3.142578125
▁rate 0.106201171875
, 2.7734375
▁ 4.12890625
5 1.7919921875
7 2.681640625
% 2.291015625
▁instead 6.265625
▁of 0.002269744873046875
▁ 0.50927734375
7 1.802734375
0 0.50439453125
% 1.4755859375
▁( 2.439453125
Fe 0.779296875
ing 0.0015230178833007812
old 0.00026917457580566406
▁et 0.01329803466796875
▁al 0.00081634521484375
., 0.006801605224609375
▁ 0.001903533935546875
2 0.00010204315185546875
0 9.083747863769531e-05
1 0.0005054473876953125
7 0.0026340484619140625
). 0.01210784912109375
▁It 1.9130859375
▁can 3.244140625
▁be 0.72021484375
▁fairly 8.46875
▁explained 1.751953125
▁by 0.1968994140625
▁the 0.293212890625
▁weak 7.421875
▁focus 6.9375
▁of 0.64306640625
▁respond 5.6484375
ents 0.106201171875
▁who 3.55078125
▁have 3.83984375
▁overcome 8.296875
▁severe 1.998046875
▁pain 0.491943359375
▁sens 7.73828125
ations 0.15234375
▁and 0.98779296875
▁de 4.8515625
press 0.7333984375
ive 0.041534423828125
▁episodes 2.068359375
. 0.43408203125
▁It 2.794921875
▁is 0.7412109375
▁not 2.443359375
▁clear 3.578125
▁how 1.9228515625
▁to 3.38671875
▁use 4.99609375
▁these 2.837890625
▁statistics 4.01953125
, 3.28125
▁as 1.365234375
▁they 1.9130859375
▁still 5.30859375
▁may 5.1328125
▁be 1.16015625
▁relevant 6.140625
▁for 1.7275390625
▁the 1.96484375
▁overall 4.85546875
▁analysis 2.564453125
. 0.8193359375
